The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
The U.S. government clarified that health insurers must cover PrEP and the associated doctor visits and tests. Here’s why.
The federal government announced that almost all health insurers must cover PrEP with no cost sharing — for the drug itself and for clinic visits and lab tests.
New guidance released by the Biden administration reminds insurers that most plans must offer HIV prevention drug PrEP without any cost-sharing to patients.
Tweets by @HIV+Hep
2 hours ago
From @bloomberglaw, @HIVHep’s Carl Schmid on health plans & #ACA requirements to offer #PrEP w/o cost-sharing: “We want everyone to know it’s free. [If] it doesn’t say ‘zero cost-sharing,’ people may not know it. So we want to make it easy as possible”: https://t.co/KqhwlLpOCL.
From @bloomberglaw, @HIVHep’s Carl Schmid on health plans & #ACA requirements to offer #PrEP w/o cost-sharing: “We want everyone to know it’s free. [If] it doesn’t say ‘zero cost-sharing,’ people may not know it. So we want to make it easy as possible”: https://t.co/KqhwlLpOCL.
20 hours ago
Should double charging patients for medication be legal? | Opinion https://t.co/NAkJ1dmpiH
Should double charging patients for medication be legal? | Opinion https://t.co/NAkJ1dmpiH